Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 4
2013 2
2015 1
2016 6
2017 1
2018 1
2019 2
2020 9
2021 15
2022 13
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritis.
Caravaca-Fontán F, Stevens K, Padrón M, Huerta A, Montomoli M, Villa J, González F, Vega C, López Mendoza M, Fernández L, Shabaka A, Rodríguez-Moreno A, Martín-Gómez A, Labrador PJ, Molina Andújar A, Prados Soler MC, Martín-Penagos L, Yerovi E, Medina Zahonero L, De La Flor JC, Mon C, Ibernon M, Rodríguez Gómez A, Miquel R, Sierra M, Mascarós V, Luzardo L, Papasotiriou M, Arroyo D, Verdalles Ú, Martínez-Miguel P, Ramírez-Guerrero G, Pampa-Saico S, Moral Berrio E, Canga JLP, Tarragón B, Fraile Gómez P, Regidor D, Relea J, Xipell M, Andrades Gómez C, Navarro M, Álvarez Á, Rivas B, Quintana LF, Gutiérrez E, Pérez-Valdivia MÁ, Odler B, Kronbichler A, Geddes C, Anders HJ, Floege J, Fernández-Juárez G, Praga M. Caravaca-Fontán F, et al. Among authors: shabaka a. Nephrol Dial Transplant. 2024 Jan 31;39(2):328-340. doi: 10.1093/ndt/gfad175. Nephrol Dial Transplant. 2024. PMID: 37550217
Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy.
Caravaca-Fontán F, Cavero T, Díaz-Encarnación M, Cabello V, Ariceta G, Quintana LF, Marco H, Barros X, Ramos N, Rodríguez-Mendiola N, Cruz S, Fernández-Juárez G, Rodríguez A, Pérez de José A, Rabasco C, Rodado R, Fernández L, Pérez-Gómez V, Ávila A, Bravo L, Espinosa N, Allende N, Sanchez de la Nieta MD, Rodríguez E, Rivas B, Melgosa M, Huerta A, Miquel R, Mon C, Fraga G, de Lorenzo A, Draibe J, González F, Shabaka A, López-Rubio ME, Fenollosa MÁ, Martín-Penagos L, Da Silva I, Titos JA, Rodríguez de Córdoba S, Goicoechea de Jorge E, Praga M; Spanish Group for the Study of Glomerular Diseases (GLOSEN). Caravaca-Fontán F, et al. Among authors: shabaka a. Kidney360. 2023 May 1;4(5):659-672. doi: 10.34067/KID.0000000000000115. Epub 2023 Mar 30. Kidney360. 2023. PMID: 36996481 Free PMC article.
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy.
Fernández-Juárez G, Rojas-Rivera J, Logt AV, Justino J, Sevillano A, Caravaca-Fontán F, Ávila A, Rabasco C, Cabello V, Varela A, Díez M, Martín-Reyes G, Diezhandino MG, Quintana LF, Agraz I, Gómez-Martino JR, Cao M, Rodríguez-Moreno A, Rivas B, Galeano C, Bonet J, Romera A, Shabaka A, Plaisier E, Espinosa M, Egido J, Segarra A, Lambeau G, Ronco P, Wetzels J, Praga M; STARMEN Investigators. Fernández-Juárez G, et al. Among authors: shabaka a. Kidney Int. 2021 Apr;99(4):986-998. doi: 10.1016/j.kint.2020.10.014. Epub 2020 Nov 7. Kidney Int. 2021. PMID: 33166580 Free article. Clinical Trial.
Validation of a Histologic Scoring Index for C3 Glomerulopathy.
Caravaca-Fontán F, Trujillo H, Alonso M, Díaz-Encarnación M, Cabello V, Ariceta G, Quintana LF, Marco H, Barros X, Ramos N, Rodríguez-Mendiola N, Cruz S, Fernández-Juárez G, Rodríguez E, de la Cerda F, Pérez de José A, López I, Fernández L, Pérez Gómez V, Ávila A, Bravo L, Lumbreras J, Allende N, Sanchez de la Nieta MD, Olea T, Melgosa M, Huerta A, Miquel R, Mon C, Fraga G, de Lorenzo A, Draibe J, González F, Shabaka A, Illescas ML, Calvo C, Oviedo V, Da Silva I, Goicoechea de Jorge E, Caravaca F, Praga M; C3G Study Group of the Spanish Group for the Study of Glomerular Diseases (GLOSEN). Caravaca-Fontán F, et al. Among authors: shabaka a. Am J Kidney Dis. 2021 May;77(5):684-695.e1. doi: 10.1053/j.ajkd.2020.11.011. Epub 2020 Dec 22. Am J Kidney Dis. 2021. PMID: 33359150
Urinary Dickkopf-3: a new biomarker for CKD progression and mortality.
Sánchez-Álamo B, García-Iñigo FJ, Shabaka A, Acedo JM, Cases-Corona C, Domínguez-Torres P, Diaz-Enamorado Y, Landaluce E, Navarro-González JF, Gorriz JL, Martínez-Castelao A, Fernández-Juárez G. Sánchez-Álamo B, et al. Among authors: shabaka a. Nephrol Dial Transplant. 2021 Dec 2;36(12):2199-2207. doi: 10.1093/ndt/gfab198. Nephrol Dial Transplant. 2021. PMID: 34145894
Emphysematous Cystitis in a Hemodialysis Patient.
Landaluce-Triska E, Dominguez-Torres P, Shabaka A. Landaluce-Triska E, et al. Among authors: shabaka a. Am J Med Sci. 2021 Oct;362(4):e33-e34. doi: 10.1016/j.amjms.2021.01.021. Epub 2021 Jan 30. Am J Med Sci. 2021. PMID: 34167796 No abstract available.
Anti-glomerular Basement Membrane Glomerulonephritis: A Study in Real Life.
Sánchez-Agesta M, Rabasco C, Soler MJ, Shabaka A, Canllavi E, Fernández SJ, Cazorla JM, López-Rubio E, Romera A, Barroso S, Huerta A, Calle L, Sierra M, Domínguez-Torres P, Moreno-Ramírez M, Afonso S, Mascarós V, Coca A, Espinosa M; Spanish Group for the Study of Glomerular Diseases (GLOSEN). Sánchez-Agesta M, et al. Among authors: shabaka a. Front Med (Lausanne). 2022 Jul 5;9:889185. doi: 10.3389/fmed.2022.889185. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35865174 Free PMC article.
Kidney Biopsy in Patients with Cancer along the Last Decade: A Multicenter Study.
Bolufer M, García-Carro C, Blasco M, Quintana LF, Shabaka A, Rabasco C, Draibe J, Merino A, Melero MR, Alonso F, Buxeda A, Batalha P, Visús MT, Soler MJ. Bolufer M, et al. Among authors: shabaka a. J Clin Med. 2022 May 21;11(10):2915. doi: 10.3390/jcm11102915. J Clin Med. 2022. PMID: 35629041 Free PMC article.
Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy.
Caravaca-Fontán F, Rivero M, Cavero T, Díaz-Encarnación M, Cabello V, Ariceta G, Quintana LF, Marco H, Barros X, Ramos N, Rodríguez-Mendiola N, Cruz S, Fernández-Juárez G, Rodríguez A, Pérez de José A, Rabasco C, Rodado R, Fernández L, Pérez-Gómez V, Ávila A, Bravo L, Espinosa N, Allende N, Sanchez de la Nieta MD, Rodríguez E, Olea T, Melgosa M, Huerta A, Miquel R, Mon C, Fraga G, de Lorenzo A, Draibe J, González F, Shabaka A, López-Rubio ME, Fenollosa MÁ, Martín-Penagos L, Da Silva I, Alonso Titos J, Rodríguez de Córdoba S, Goicoechea de Jorge E, Praga M. Caravaca-Fontán F, et al. Among authors: shabaka a. Clin Kidney J. 2022 Apr 28;15(9):1737-1746. doi: 10.1093/ckj/sfac108. eCollection 2022 Sep. Clin Kidney J. 2022. PMID: 36003665 Free PMC article.
52 results